Lumbard Investment Counseling »

Eton Pharmaceuticals shares owned by Lumbard Investment Counseling

Quarter-by-quarter ownership of Eton Pharmaceuticals (ETON) shares owned by Lumbard Investment Counseling from 13F filings

Historical chart of Lumbard Investment Counseling investment in Eton Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eton Pharmaceuticals held by Lumbard Investment Counseling consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eton Pharmaceuticals by Lumbard Investment Counseling

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.8M 176k 21.73

More positions owned by Lumbard Investment Counseling

Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Spdr Portfolio S&p 400 Mid Cap Etf Etf (SPMD)
Goldman Sachs Group Stock (GS)
Kratos Defense & Sec Solutions Stock (KTOS)
First Solar Stock (FSLR)
Metlife Stock (MET)
Hudbay Minerals Stock (HBM)
Cisco Sys Stock (CSCO)
Kinder Morgan Inc Del Stock (KMI)
Freedom 100 Emerging Markets Etf Etf (FRDM)
Vanguard International High Dividend Yield Etf Etf (VYMI)
Petroleo Brasileiro Sa Petrobr Adr (PBR)
Materion Corp Stock (MTRN)
Amazon Stock (AMZN)

View all positions for Lumbard Investment Counseling

Top funds holding Eton Pharmaceuticals

Opaleye Management
EcoR1 Capital
BlackRock
Vanguard Group
Nantahala Capital Management
Geode Capital Management
Morgan Stanley
Royal Bank of Canada
Westside Investment Management
Cannell Capital
State Street Corporation
Thompson, Siegel, & Walmsley
Jpmorgan Chase & Co
Renaissance Technologies
Divisadero Street Capital Management

View all funds holding Eton Pharmaceuticals